Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 23, 2023
Progress in characterizing ABC multidrug transporters in zebrafishJoanna R Thomas, William J E Frye, Robert W Robey, et al.
Chemico-Biological Interactions|April 4, 2024
The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across speciesJosé M González Dalmasy, Christina M Fitzsimmons, William J E Frye, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
The thiol methyltransferase activity of TMT1A (METTL7A) is conserved across speciesJosé M González Dalmasy, Christina M Fitzsimmons, William J E Frye, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
The Multidrug Resistance Transporter P-glycoprotein Confers Resistance to Ferroptosis InducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Cancer Drug Resistance (Alhambra, Calif.)|October 16, 2023
The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducersWilliam J E Frye, Lyn M Huff, José M González Dalmasy, et al.
Fluids and Barriers of the CNS|March 16, 2024
Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrierJoanna R Thomas, William J E Frye, Robert W Robey, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrierJoanna R Thomas, William J E Frye, Robert W Robey, et al.
Acta Neuropathologica Communications|April 8, 2024
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma modelSanghee Lim, Minhye Kwak, Jeonghan Kang, et al.
Molecular Cancer Therapeutics|December 28, 2023
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase InhibitorsRobert W Robey, Christina M Fitzsimmons, Wilfried M Guiblet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E Hebron, Xiaolin Wan, Jacob S Roth, et al.
Pageof 1